StockWatch
·
Pharmaceuticals
Quarterly Result29 May 2026, 10:31 pm

Sunil Healthcare: FY26 Audited Results Approved

AI Summary

Sunil Healthcare Ltd. has announced the approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors, in its meeting held on May 29, 2026, also noted the auditor's report with an unmodified opinion and did not recommend any dividend for the financial year 2025-26. Additionally, M/s. Agrawal S. Lal & Co. were appointed as Internal Auditors for the financial year 2026-27.

Key Highlights

  • Approved audited financial results (standalone and consolidated) for FY26.
  • No dividend was recommended for the financial year 2025-26.
  • M/s. Agrawal S. Lal & Co. appointed as Internal Auditors for FY27.
  • Standalone revenue from operations for FY26 is ₹8,771.92 Lakhs.
  • Consolidated revenue from operations for FY26 is ₹8,771.92 Lakhs.